(RF) Eurazeo - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121121
RF EPS (Earnings per Share)
RF Revenue
RF: Private Equity, Venture Capital, Real Estate, Asset Management, Investments
Eurazeo SE is a versatile private equity and venture capital firm that invests in a wide range of sectors, including smart cities, services, leisure, mobility, real estate, fintech, and healthcare, with a focus on medium-sized to large companies, SMEs, and high-growth businesses. The firms investment strategy is centered around identifying companies with differentiated concepts and global growth potential, driven by digital transformation and changes in lifestyle and consumption patterns.
The firms investment portfolio is diversified across various geographies, including the United States, Europe, and China, with a focus on large properties, residential, commercial, and office development projects, as well as companies with real estate assets in Western Europe. Eurazeos investment size varies depending on the type of business, ranging from €10 million to €250 million, with a focus on small to mid-buyout businesses, growth businesses, and companies with significant growth potential.
From a technical analysis perspective, Eurazeos stock price has been trending downwards, with the current price at €61.00, below its SMA20 and SMA50 levels. The stocks ATR indicates a moderate level of volatility, with a 52-week high of €77.23 and a low of €52.37. Considering the firms strong RoE of 17.89% and its diversified investment portfolio, a potential forecast for the stock price could be a gradual recovery towards its SMA50 level, potentially reaching €62-€65 in the short term, driven by the firms continued investment activities and growth prospects.
Fundamentally, Eurazeos market capitalization stands at €4.42 billion, with a strong presence in the asset management and custody banks sector. Although the firms P/E ratio is not available, its RoE suggests a robust financial performance. Given the firms diversified investment portfolio and its focus on growth businesses, a potential long-term forecast for the stock price could be a steady appreciation, potentially reaching €70-€75, driven by the firms continued growth and expansion into new markets.
Additional Sources for RF Stock
RF Stock Overview
Market Cap in USD | 5,088m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception |
RF Stock Ratings
Growth Rating | 21.7 |
Fundamental | 24.5 |
Dividend Rating | 74.3 |
Rel. Strength | -33.4 |
Analysts | - |
Fair Price Momentum | 55.50 EUR |
Fair Price DCF | - |
RF Dividends
Dividend Yield 12m | 4.16% |
Yield on Cost 5y | 6.68% |
Annual Growth 5y | 12.70% |
Payout Consistency | 92.7% |
Payout Ratio | 8.6% |
RF Growth Ratios
Growth Correlation 3m | -27.4% |
Growth Correlation 12m | -40.2% |
Growth Correlation 5y | 49.9% |
CAGR 5y | 8.06% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 1.15 |
Alpha | -30.15 |
Beta | 0.899 |
Volatility | 25.94% |
Current Volume | 90.3k |
Average Volume 20d | 110.4k |
As of June 15, 2025, the stock is trading at EUR 58.95 with a total of 90,281 shares traded.
Over the past week, the price has changed by -3.36%, over one month by -11.10%, over three months by -12.67% and over the past year by -17.09%.
Neither. Based on ValueRay´s Fundamental Analyses, Eurazeo is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.54 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RF is around 55.50 EUR . This means that RF is currently overvalued and has a potential downside of -5.85%.
Eurazeo has no consensus analysts rating.
According to our own proprietary Forecast Model, RF Eurazeo will be worth about 63.1 in June 2026. The stock is currently trading at 58.95. This means that the stock has a potential upside of +6.97%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 87.5 | 48.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 63.1 | 7% |